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Abstract
 
The constraint of fitting a diverse repertoire of antigen specificities in a limited total population
of lymphocytes results in the frequency of naive cells specific for any given antigen (defined as
the precursor frequency) being below the limit of detection by direct measurement. We have
estimated this precursor frequency by titrating a known quantity of antigen-specific cells into
naive recipients. Adoptive transfer of naive antigen-specific T cell receptor transgenic cells into
syngeneic nontransgenic recipients, followed by stimulation with specific antigen, results in ac-
tivation and expansion of both donor and endogenous antigen-specific cells in a dose-depen-
dent manner. The precursor frequency is equal to the number of transferred cells when the
transgenic and endogenous responses are of equal magnitude. Using this method we have esti-
mated the precursor frequency of naive CD8 T cells specific for the H-2D
 
b
 
–restricted GP33–41
epitope of LCMV to be 1 in 2 
 
 
 
 10
 
5
 
. Thus, in an uninfected mouse containing 
 
 
 
2-4 
 
 
 
 10
 
7
 
naive CD8 T cells we estimate there to be 100–200 epitope-specific cells. After LCMV infec-
tion these 100–200 GP33-specific naive CD8 T cells divide 
 
 
 
14 times in 1 wk to reach a total
of 
 
 
 
10
 
7
 
 cells. Approximately 5% of these activated GP33-specific effector CD8 T cells survive
to generate a memory pool consisting of 
 
 
 
5 
 
 
 
 10
 
5
 
 cells. Thus, an acute LCMV infection re-
 
sults in a 
 
 
 
1,000-fold increase in precursor frequency of D
 
b
 
GP33-specific CD8 T cells from
2 
 
 
 
 10
 
2
 
 naive cells in uninfected mice to 5 
 
 
 
 10
 
5
 
 memory cells in immunized mice.
Key words: lymphocytic choriomeningitis virus • T cell antigen receptors • adoptive transfer • 
cellular immunity • CD8-positive T lymphocytes
 
Introduction
 
Two cardinal properties of the adaptive immune system are
specificity and diversity; thus the immune system can
mount exquisitely specific responses to a vast repertoire of
possible antigens. As the immune system must accommo-
date this diversity within a relatively limited total popula-
tion size there must be compromise between the repertoire
of different antigens the immune system can effectively rec-
ognize and the number of precursors with any given speci-
ficity. Recent technical advances including the use of
 
MHC class I tetramers complexed with defined viral peptide
epitopes and measurement of the production of cytokines in
response to stimulation with synthetic peptides have allowed
CD8 T cell responses to be quantitated with great accu-
 
racy. However, neither method is sufficiently sensitive to
measure the low frequency of naive antigen-specific T
cells before expansion during the generation of an immune
response (1–4).
The CD8 T cell response in C57Bl/6J mice to the
Armstrong strain of lymphocytic choriomeningitis virus
(LCMV) results in a rapid rise in the number of LCMV-
specific CD8 T cells from below the threshold of detection
(
 
 
 
 
 
 
 
1,000 cells/mouse) to 
 
 
 
10
 
7
 
 antigen-specific CD8 T
cells by 8 d after infection (3, 4). This expansion is followed
by a death phase, during which there is approximately a
10-fold reduction in the number of LCMV-specific CD8
T cells from days 8 to 30, and thereafter the stable mainte-
nance of an antigen-specific memory population. One of
the immunodominant T cell responses elicited during this
response is specific for the H-2D
 
b
 
–restricted glycoprotein
(GP33–41) epitope of LCMV. Although analysis of the T
cell receptors within this epitope-specific population has
shown a heterogeneous usage of TCR V
 
 
 
 gene segments
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(5, 6) adoptive transfer of excessive numbers of CD8 T
cells from mice bearing a transgene encoding a TCR spe-
cific for this epitope (7), followed by challenge with
LCMV, results in a highly restricted D
 
b
 
GP33 response us-
ing primarily the transgenic TCR V
 
 
 
8.1 and V
 
 
 
2 TCR
segments (8, 9).
In this paper we describe a novel approach for quantitat-
ing the precursor frequency of naive antigen-specific CD8
T cells in a polyclonal population. We adoptively trans-
ferred limiting numbers of naive antigen-specific TCR
transgenic (TCR-Tg) CD8 cells (specific for the D
 
b
 
GP33
epitope) into nontransgenic syngeneic recipients and then
measured the fraction of the epitope-specific response con-
tributed by donor and endogenous cells after LCMV infec-
tion. In this quantitative-competitive system, adoptive
transfer of increasing numbers of specific transgenic cells
resulted in a greater fraction of the antigen-specific re-
sponse arising from donor cells. If donor and endogenous
epitope-specific cells have the same participation and pro-
liferative properties, then the relationship between the
number of transferred transgenic cells (
 
T
 
) and the fraction
of the GP33 response which is transgenic (
 
F
 
) is given by:
, (1)
where 
 
P
 
 is equal to the precursor frequency of endogenous
epitope-specific cells. In the special case when the number
of transferred cells equals the endogenous precursor fre-
quency (i.e., 
 
T
 
 
 
 
 
 
 
P
 
), half of the GP33-specific response
will be generated by transgenic cells (
 
F
 
 
 
 
 
 1/2). Using this
experimental approach, we have measured the naive anti-
gen-specific CD8 T cell precursor frequency in mice. Fur-
thermore, we have verified that endogenous and donor
transgenic epitope-specific cells have similar proliferative
properties in response to antigenic stimulation in vivo and
that transfer of exogenous cells does not significantly alter
the magnitude or composition of the endogenous D
 
b
 
GP33
CD8 T cell response.
 
Materials and Methods
 
Animals and Virus.
 
6–8-wk-old female C56Bl/6J (B6) or P14
B6.D2-TgN (TCR-Tg) mice were obtained from The Jackson
Laboratory. TCR-Tg mice were backcrossed to B6 background
(
 
 
 
10 generations) at the Emory University animal facility before
use. The Armstrong and clone-13 strains of LCMV were grown
as previously described (10). The recombinant vaccinia virus ex-
pressing the GP33–41 epitope (VV-GP33) was generated and
grown as described previously (11). For primary infections and
generating immune mice, B6 mice were given 2 
 
 
 
 10
 
5
 
 PFU of
LCMV (Armstrong) intraperitoneally. For secondary infections,
immune mice were given either 2 
 
 
 
 10
 
6
 
 PFU of LCMV (clone-
13) intravenously or 10
 
7
 
 PFU of VV-GP33 intraperitoneally and
assayed 5 d after infection. For chronic infection, naive B6 mice
were given 2 
 
 
 
 10
 
6
 
 PFU of LCMV (clone-13) intravenously.
 
Antibodies and MHC Tetramers.
 
Anti-CD8
 
 
 
 (Lyt-2, clone 53–
6.7), anti-V
 
 
 
2 TCR (clone B20.1), and anti-V
 
 
 
8.1,8.2 TCR
(clone MR5–2) antibodies as well as the panel of anti-V
 
 
 
 anti-
bodies were purchased from BD PharMingen. The anti-D
 
b
 
 anti-
F T
TP +
------------- ≈
 
body (clone 28–14–8) was generated from the HB-27 hybridoma
(American Type Culture Collection) and F
 
ab
 
 fragments prepared
using the Immunopure F
 
ab
 
 preparation kit (Pierce Chemical Co.)
in accordance with manufacturer’s directions. H-2D
 
b
 
 MHC class
I tetramer complexes were refolded with synthetic GP33–41 pep-
tide (KAVYNFATM) and prepared as previously described (3,
12). Biotinylated monomeric D
 
b
 
GP33 complexes were assembled
into tetramers by the addition of allophycocyanin-conjugated
streptavidin (Molecular Probes) in a 4:1 molar ratio.
 
Cells and Flow Cytometry.
 
Single cell suspensions of spleno-
cytes were prepared as described previously (3). Peripheral blood
lymphocytes were separated from whole blood over Histo-
paque
 
®
 
-1077 (Sigma-Aldrich) in accordance with manufacturer’s
recommendations. Cells were resuspended in FACS
 
®
 
 buffer (PBS
containing 2% bovine serum albumin and 0.2% sodium azide)
and stained with the indicated reagents at a final concentration of
1 
 
 
 
g/ml for 30 min at 4
 
 
 
C. Cells were then washed twice in
FACS
 
®
 
 buffer, fixed in a 2% paraformaldehyde solution, and im-
mediately acquired on a FACSCalibur™ flow cytometer (Becton
Dickinson).
 
TCR Affinity Measurement by MHC Tetramer Fall-Off Assay.
 
Measurement of relative TCR affinity by a competitive tetramer
fall-off assay was done as described previously (13). Briefly, 2 
 
 
 
10
 
7
 
 splenocytes from infected mice were stained with the
D
 
b
 
GP33 tetramer and anti-CD8, -V
 
 
 
2 antibodies as described
above. After two washes, cells were incubated with or without
unlabeled competitor anti-D
 
b
 
 antibody F
 
ab
 
 (clone 28–14–8f) at 2
mg/ml in FACS
 
®
 
 buffer at 4
 
 
 
C. At the indicated times, 100-
 
 
 
l
aliquots were removed and added to an equal volume of 2% PFA
in PBS and immediately acquired on a FACSCalibur™ flow cy-
tometer. Normalized total fluorescence less background staining
was calculated using the following formula: NTF
 
time i
 
 
 
 
 
 (% pos. 
 
 
 
MFI)
 
time i
 
/(% pos. 
 
 
 
 MFI)
 
time 0
 
.
 
Adoptive Transfer of TCR-Tg Cells.
 
For cell transfers, single
cell suspensions of splenocytes from naive P14 TCR-Tg trans-
genic mice, bearing TCR specific to the D
 
b
 
GP33 epitope of
LCMV, were injected intravenously into the tails of recipient
mice and infected 2 d after transfer. To account for differences in
engraftment of such limited numbers of cells, splenocytes from
naive P14 TCR-Tg transgenic mice were diluted in naive B6
splenocytes such that a constant number of total cells (2 
 
 
 
 10
 
6
 
)
were transferred into recipients receiving different doses of trans-
genic cells. For transfer of purified CD8
 
 
 
 populations, cells were
positively selected by MACS separation (Miltenyi Biotec) in ac-
cordance with manufacturer’s directions and purity determined
(normally 
 
 
 
90%) by flow cytometry before transfer.
 
Results and Discussion
 
Measurement of Precursor Frequency.
 
Adoptive transfer of
an increasing number of naive TCR-Tg CD8 T cells into
nontransgenic syngeneic recipients, followed by challenge
with LCMV results in an increasing proportion of the
D
 
b
 
GP33-specific response being contributed by donor cells
(Fig. 1). Donor TCR-Tg cells were designated as CD8 T
cells which specifically bound the D
 
b
 
GP33 tetramer as well
as expressed both the V
 
 
 
2 (Fig. 1 A) and V
 
 
 
8.1 (Fig. 1 B)
TCR gene segments. When no cells were transferred,
 
 
 
5% of cells that bound the D
 
b
 
GP33 tetramer used both
the V
 
 
 
2 and V
 
 
 
8.1 TCR gene segments. Because only a
very small fraction (
 
 
 
5%) of the endogenous response had
the same TCR V
 
 
 
 and V
 
 
 
 gene usage as the donor trans- 
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genic cells, we were able to use V
 
 
 
2
 
 
 
V
 
 
 
8.1
 
 
 
D
 
b
 
GP33
 
 
 
CD8
 
 
 
 cells to follow the donor transgenic response. The
transgenic proportion of the D
 
b
 
GP33 response increased
with the number of cells transferred and at the highest
doses, the response was dominated by donor transgenic
cells (
 
 
 
98%). Similar results were seen when Thy1.1
 
 
 
TCR-Tg cells were transferred into Thy1.2
 
 
 
 recipients us-
ing the Thy1 marker to distinguish between donor and
host responses (data not shown).
Calculation of precursor frequency requires accurate es-
timation of the engraftment or “take” of these donor cells
in recipient mice. We observed that 
 
 
 
10% of total donor
populations were recoverable from spleens of recipient
mice 2 d after transfer (Fig. 2 A). In addition, splenic re-
covery did not differ after transfer of either polyclonal cells
(measuring a congenic difference at the Thy1 locus) or cells
from TCR-Tg mice. Using 10% as an estimate of the
number of transferred cells which persist in the spleens of
recipient mice, we plotted the transgenic fraction of the
D
 
b
 
GP33-specific CD8 T cell response versus the number
of donor transgenic cells engrafted (Fig. 1 C). The fraction of
the D
 
b
 
GP33-specific response attributable to donor cells in-
creased with the amount of cells transferred in a dose-depen-
dent manner. The transgenic fraction of the D
 
b
 
GP33-spe-
cific response closely followed predicted values, namely
fraction transgenic (
 
F
 
) is equal to the number of transgenic
precursors transferred divided by the total number of pre-
cursors (
 
T
 
/[
 
T
 
 
 
P
 
]). This allowed us to estimate the number
of endogenous D
 
b
 
GP33-specific precursors in the spleen
either by the best fit to this equation or by the number of
transferred transgenic cells at which half the response was
transgenic. We thus estimated that there are on average 56
(range 46–65: 
 
 
 
95% confidence interval) endogenous
D
 
b
 
GP33-specific precursors per spleen in uninfected mice.
Figure 1. Adoptive transfer of
increasing numbers of DbGP33-
specific TCR Tg CD8  T cells
(V 2 V 8.1 ), followed by
challenge with LCMV, results in
an increasing proportion of the
total epitope-specific response
being contributed by donor
cells. (A) Analysis of recipient
mice after viral challenge. Con-
tour plots are gated on CD8  T
cells and percentages indicate
the relative proportions of
DbGP33  cells that are V 2  or
V 2 . Numbers above each
plot indicate the number of
TCR-Tg CD8  T cells trans-
ferred. (B) Analysis of V 8.1 us-
age by epitope-specific cells.
Histograms are gated on
CD8 DbGP33 V 2  cells. Per-
centages under each histogram
indicate the total V 2 V 8.1 
portion of the DbGP33-specific
CD8  T cell response. (C) The
donor TCR-Tg fraction of the
epitope-specific response is plotted
vs. the number of TCR-Tg cells
engrafted. Open symbols circles
represent mice that were given
only TCR-Tg cells, while filled
circles represent mice which
were given TCR-Tg cells di-
luted in 2   106 naive polyclonal
B6 splenocytes. The solid line is
the best fit to the equation F  
T/(T   P) while the dashed line
indicates the dose of donor cells
at which 50% of the DbGP33-
specific response is endogenous. 
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Given that there are on average 10
 
7
 
 naive CD8 T cells in
the spleens of uninfected mice, this translates to an epitope-
specific precursor frequency of 1 in 2 
 
 
 
 10
 
5
 
.
This estimate of precursor frequency depends upon sev-
eral assumptions: accurate measurement of the engraftment
or “take” of donor cells, similar proliferation of transgenic
and polyclonal epitope-specific populations in response to
antigenic stimulation, and that addition of increasing num-
bers of donor epitope-specific cells does not qualitatively
change the recruitment from the endogenous epitope-spe-
cific pool. We have tested these assumptions directly and
accounted for them in our estimate of precursor frequency.
 
Engraftment of Donor Cells.
 
We have defined engraft-
ment or “take” as the percentage of total donor cells that
are recoverable from spleens of recipient mice and have
measured this to be 10% for large populations of either
polyclonal or transgenic donor CD8 T cells. It is possible
the number of donor cells surviving may (due to homeo-
static mechanisms that limit the total number of naive CD8
T cells) diminish as increasing numbers of cells are trans-
ferred. To compensate for any variance due to the size of
the transferred population, donor TCR-Tg cells were di-
luted in naive polyclonal cells such that in all cases, a con-
stant number of total cells (2 
 
 
 
 10
 
6
 
 splenocytes) were
transferred. As shown in Fig. 1 C, the fraction of the
D
 
b
 
GP33-specific CD8 T cell response attributable to trans-
genic donor cells was similar whether these were trans-
ferred alone (open symbols) or in the context of a larger
population of polyclonal cells (filled symbols). Thus, our
measurements demonstrate similar precursor frequency and
engraftment of donor cells in recipient spleens regardless of
the total number of cells transferred in these experiments.
Also, it is unlikely that D
 
b
 
GP33-specific precursors in the
donor polyclonal population made any significant contri-
bution to the response as, given our estimate of precursor
frequency, on average 
 
 
 
1 antigen-specific cell is present in
this population.
To directly compensate for any variance in the engraft-
ment of donor transgenic cells into resident endogenous
polyclonal populations, we transferred 10
 
8
 
 polyclonal
Thy1.1
 
 
 
/
 
 
 
 CD8 T cells (containing 
 
 
 
500 D
 
b
 
GP33-spe-
cific precursors given our estimate) mixed with 500
epitope-specific Thy1.1
 
 
 
/Thy1.2
 
 
 
 TCR-Tg CD8 T cell
precursors into naive irradiated Thy1.2
 
 
 
/
 
 
 
 recipient mice.
These mice were then challenged with LCMV and their
D
 
b
 
GP33-specific Thy1.1
 
 
 
 CD8 T cell response measured.
If both the engraftment and proliferation of virus specific
cells within these donor populations were similar, then
roughly 50% of the D
 
b
 
GP33-specific CD8 Thy1.1
 
 
 
 T cell
response would be due to each donor population. We ob-
served a 2:1 ratio of polyclonal (Thy1.2
 
 
 
) to TCR-Tg
(Thy1.2
 
 
 
) responders in challenged recipient mice (Fig. 2
B). Given the experimental constraints of transferring such
a large number of CD8 T cells as well as genetic back-
ground differences in these strains, this indicates that our
estimate of precursor frequency is off by at most a factor of
2. This would give an antigen-specific precursor frequency
of 10
 
 
 
5
 
 naive CD8 T cells in mice.
 
Transgenic and Endogenous GP33-specific Cells Have Similar
Proliferative Properties.
 
In addition to accurate measure-
ment of the donor cell “take,” our precursor measurement
also depends on transgenic and endogenous D
 
b
 
GP33-spe-
cific CD8 T cells possessing similar proliferative properties
during an immune response. To test the inherent prolifera-
tive “fitness” of transgenic and endogenous D
 
bGP33-spe-
cific cells, we followed the increase in magnitude of each
population and the ratio of endogenous to transgenic cells
in individual mice during secondary responses to either
LCMV or a vaccinia virus expressing the GP33 epitope
(VV-GP33) (8, 11, 14). During recall responses in LCMV-
rechallenged mice, both donor transgenic and endogenous
DbGP33-specific CD8 T cells underwent expansion, with
an approximately fivefold increase in frequency. A consid-
erably greater expansion of both donor and endogenous
populations ( 20-fold) was seen in mice rechallenged with
VV-GP33. However, in both recall responses the ratio of
endogenous to TCR-Tg donor DbGP33-specific CD8 T
cells in individual mice did not change significantly during
the secondary response compared with that seen before re-
challenge (Fig. 3). These data indicate that polyclonal and
transgenic cells do not have any significant proliferative dif-
ferences that would skew our estimate of precursor fre-
quency and that donor and endogenous DbGP33-specific
CD8 T cells behave similarly following antigenic stimula-
tion in vivo.
Another potential factor that could affect the prolifera-
tion of donor and endogenous DbGP33-specific CD8 T
cells is competition and/or differential participation in the
immune response due to differences in the TCR affinity of
these two populations. As the transgene encoding the P14
Figure 2. Engraftment of TCR-Tg and polyclonal B6 CD8  T cells
are similar. (A) Splenocytes from either TCR-Tg or B6 (Thy1.1 ) mice
were injected into naive, nonirradiated B6 (Thy1.2 ) recipients. Percent-
ages indicate the fraction of naive TCR-Tg or B6 donor CD8  T cells
recoverable from spleens of recipient mice 2 d after transfer. Each bar rep-
resents  10 mice and error bars indicate standard deviation from the
mean. (B) To discount differences in survival of TCR-Tg vs. B6 cells, 108
purified polyclonal CD8  cells from C57Bl/6 Thy1.1  mice (which,
given our estimates, contains  500 precursor cells) were mixed with 500
purified TCR-Tg Thy1.1 /Thy1.2  CD8  cells. These were then in-
jected into naive B6 Thy1.2  recipients. After challenge with LCMV,
epitope-specific donor cells (Thy1.1 ) from recipient mice were analyzed
for Thy1.2 (TCR Tg only) expression. Percentages indicate the propor-
tion of the CD8 DbGP33 Thy1.1  response due to TCR-Tg (Thy1.2 )
or polyclonal B6 (Thy1.2 ) donor cells.661 Blattman et al. Brief Definitive Report
TCR is derived from a polyclonal response, the affinity of
the transgenic TCR for its DbGP33 ligand must be con-
tained within the spectrum of TCR affinities of the poly-
clonal DbGP33-specific response (7). We have measured
the relative affinities of transgenic and polyclonal DbGP33-
specific CD8 T cells in competitive tetramer fall-off assays
(13, 15). The DbGP33-specific TCR-Tg cells have initial
fall-off rates similar to that of the polyclonal population (see
Fig. 5 A). Similar to published reports, the tetramer fall-off
rate from P14 TCR transgenic cells proceeds with linear
first-order decay kinetics. However, although the vast ma-
jority of endogenous polyclonal DbGP33-specific CD8 T
cells follow similar kinetics, quantitative analysis of this
population is complicated by its broad TCR diversity (5).
As lower affinity cells are lost from the sample population
during the course of the assay, the overall affinity of the re-
mainder is increased (see Fig. 5 B). Thus, there may be a
minor population of higher affinity endogenous DbGP33-
specific CD8 T cells; precisely what one would predict if
the narrow affinity of the transgenic TCR falls within a
broader spectrum of polyclonal TCR with both higher and
lower affinities.
Antigen Availability and the Magnitude of the Endogenous
Response. Our measurement of precursor frequency may
also have been affected by skewing of the endogenous re-
sponse when increasing numbers of TCR-Tg cells are
transferred (for example if competition for antigen af-
fected recruitment of endogenous epitope-specific pre-
cursors). Thus, if the total number of precursors recruited
into a given response were limited to a finite number,
transfer of increasing numbers of donor cells may result in
a partial participation by endogenous epitope-specific pre-
cursors. In the range where we have measured the endog-
enous precursor frequency, we observed little change in
the magnitude of the endogenous DbGP33-specific re-
sponse when low numbers of donor cells were transferred
(Fig. 4 A). However, as transgenic cells became saturat-
ing, the endogenous response was effectively suppressed.
Thus, in the range where we have measured precursor
frequency antigen does not appear to be limiting, but as
transgenic precursors become saturating, the viral infec-
tion is controlled faster and thus prevents recruitment
from the endogenous pool.
We have directly determined the influence of antigen
availability on our estimate of precursor frequency by in-
creasing the viral burden and thus antigen load in recipient
mice. Mice infected with the more virulent clone-13
strain of LCMV showed prolonged viremia and higher
levels of DbGP33-specific CD8 T cell expansion in this
system (data not shown). However, despite this larger ex-
Figure 3. TCR-Tg and polyclonal B6 epitope-spe-
cific CD8  T cells have similar proliferative properties.
LCMV immune mice containing a mixture of TCR-Tg
and endogenous DbGP33-specific CD8  T cells were
rechallenged with either LCMV (clone-13) (A) or a
vaccinia virus expressing the GP33 epitope (VV-GP33)
(B). PBMCs were analyzed for the frequency of
DbGP33-specific cells (bar graphs, left axis) as well as
the fraction of the DbGP33  response from individual
mice due to donor TCR-Tg cells (right axis) before
(memory) and after (secondary) rechallenge. Graphs in-
dicate mean frequency of antigen specific cells ( 6
mice per group) and error bars indicate standard devia-
tion from the mean.
Figure 4. No suppression of
the endogenous DbGP33-spe-
cific CD8  T cell response due
to limited antigen availability.
(A) No suppression of the en-
dogenous response was observed
in the range of precursor fre-
quency. Mice receiving differ-
ent numbers of DbGP33-specific
TCR Tg CD8  T cells were
challenged with LCMV and 7 d
after infection, splenocytes were
analyzed by flow cytometry. The
magnitude of the endogenous
polyclonal (open circles) and do-
nor transgenic (filled circles)
DbGP33-specific CD8  response
is shown per spleen versus the number of engrafted donor cells. (B) Increased antigen load results in precisely the same dose dependence of donor cells.
Mice receiving different numbers of donor TCR-Tg cells were challenged with LCMV (ARM) (circles) or the more virulent LCMV (clone-13) (trian-
gles). Plotted is the fraction of the response due to donor cells versus the number of donor cells engrafted.662 Estimating Naive T Cell Precursor Frequency
pansion, we observed precisely the same dose dependence
of transgenic cells in LCMV (clone-13) infected mice
(measuring the transgenic fraction of the DbGP33 re-
sponse) as in LCMV (Armstrong) infected mice (Fig. 4 B).
Thus in either case, all available precursors were able to
participate in the antiviral response indicting that our mea-
surement of precursor frequency is not skewed by avail-
ability of antigen or suppression of the endogenous
DbGP33 response. Also, increasing antigen load minimizes
competition between cells with potentially different TCR
affinities, further arguing against differences in participa-
tion between transgenic and polyclonal DbGP33-specific
CD8 T cells due to TCR affinity.
Affinity and Diversity of the Endogenous Response. Another
factor that could potentially influence our estimate of pre-
cursor frequency is recruitment of a different subset of en-
dogenous DbGP33-specific CD8 T cell precursors. We
have directly measured both the affinity and diversity the
endogenous responses in the range where we have mea-
sured precursor frequency. We observed no change in the
affinity (as measured by the tetramer fall-off assay) of the
endogenous DbGP33 CD8 T cell response (V 2 ) when
an increasing proportion of the DbGP33 response was due
to donor TCR-Tg cells (Fig. 5 B). Thus, endogenous
DbGP33-specific CD8 T cell populations had precisely the
same affinity regardless of whether 0%,  33%, or  66% of
the response was contributed by donor cells. Additionally,
we have compared the TCR diversity of the endogenous
(V 2 ) DbGP33 CD8 T cells as increasing numbers of do-
nor TCR-Tg cells were transferred. We observed no sig-
nificant difference in the TCR diversity (in terms of TCR-
V  gene segment usage) of the endogenous DbGP33 CD8
T cells in mice that received no transgenic cells or whose
response was  50% transgenic (Fig. 5 C). Thus, in the
range where we are measuring precursor frequency, we do
not significantly affect the affinity or diversity of the endog-
enous DbGP33 CD8 T cell response.
Implications. We have defined precursor frequency as
the number of naive CD8 T cells specific for a given pep-
tide-MHC combination in mice before antigenic chal-
lenge and have estimated this to between 10 5 and 2  
10 5 or 50–100 cells/spleen. It has been estimated that an
adult uninfected mouse contains between 2–4   107 naive
CD8  T cells. Based on this, we thus estimate that there
are between 100–200 naive CD8 T cells specific for the
DbGP33 epitope in an adult uninfected mouse. Certainly,
an upper-bound estimate of the total number of antigen-
specific CD8 T cells present would be equal to the 500
cells originally transferred.
As the response to a given epitope generally involves
several different T cell clones the average precursor fre-
quency per clone will be the precursor frequency per
epitope divided by the number of clones (5, 6, 16–19). The
total T cell clonal diversity has recently been estimated for
humans (20) and mice (21). In mice at least 2   106 unique
TCR were estimated. The reciprocal of this clonal diver-
sity estimate in mice yields a clonal T cell frequency esti-
mate of 2   10 6. This study also found a redundancy of
 10 cells/unique TCR sequence (21). As it has been esti-
mated that in a given epitope-specific T cell response  20
different clones participate (18, 19), this would indicate that
on average 200 cells participate in an epitope-specific re-
sponse, very similar to our estimate of the number of
DbG33-specific precursors present in naive mice. Addition-
ally, even though the clonal diversity in humans is in-
creased only 10-fold, it has been estimated that there are
 10,000-fold more CD8 T cells in humans compared with
mice.
Although we have shown that the precursor frequency,
defined as the total number of CD8 T cells specific for the
DbGP33 epitope of LCMV, is 1 in 2   105, the precise re-
lationship between this precursor frequency and the diver-
sity of epitopes which could potentially be recognized is
complex, dependent on both overlapping TCR specifici-
Figure 5. Transfer of increasing numbers of donor cells does not affect the TCR affinity or diversity of the endogenous DbGP33 response. TCR affin-
ity. (A) Relative TCR affinity of P14 TCR transgenic (filled circles) versus polyclonal (open circles) DbGP33-specific CD8 T cells. For quantitative com-
parison of tetramer fall-off kinetics, data are shown as the ( ) change in normalized total fluorescence (NTF, as described in Materials and Methods) over
time. The mean (  SD) slope of each interval is equivalent to (NTFi   NTFi-1)/t where t is the length of the time interval. (B) Relative TCR affinity of
endogenous DbGP33-specific CD8 T cells from mice whose DbGP33 response was completely due to endogenous cells (circles), 25–33% donor cells (tri-
angles), or 66–75% donor cells (squares) were analyzed by tetramer fall-off assay as described. (C) TCR diversity. Endogenous DbGP33-specific CD8 T
cells from mice containing either completely endogenous (open circles) or 50% transgenic DbGP33 cells (filled circles) were analyzed for TCR-V  usage
using a panel of monoclonal antibodies. Shown is the percentage of the endogenous (V 2 ) DbGP33 response using each V  gene segment.663 Blattman et al. Brief Definitive Report
ties as well as the clonality of any given response. However
the inverse of the precursor frequency provides a lower
bound to the total number of epitopes that can be recog-
nized, implying that at least 2   105 different epitopes may
be recognized in mice.
In addition to obtaining an epitope-specific precursor
estimate, this data also provides us with a more accurate
estimate of the total number of divisions seen in LCMV-
specific CD8 T cells during infection of mice. At the peak
of the immune response to LCMV (8 d after infection),
the number of DbGP33-specific CD8 T cells is roughly
107 (3, 4). Thus, there is a  50,000-fold increase in the
number of epitope-specific CD8 T cells during the re-
sponse to viral infection. Assuming there is very little
death of antigen specific cells during this period (days 0–8),
this also indicates that this cell population would have had
to undergo on average  14 divisions. After the peak of
this response, most of the virus-specific CD8 T cells un-
dergo apoptosis, leaving behind a stable memory pool
containing  5   105 DbGP33-specific CD8 T cells. Thus,
in immune mice there is a  5,000-fold net increase in the
number of antigen-specific cells contained in the memory
CD8 T cell population.
The interrelationship between the specificity and diver-
sity of T cell responses remain central to understanding the
generation of immune responses to all pathogens. Estimat-
ing these parameters accurately is a first step in this process
and facilitates a clearer understanding of the balance main-
tained in naive T cell repertoires versus the expansion of
antigen-specific populations.
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